| Withdrawn | A Study of ONC201 for Refractory Meningioma NCT06012929 | University of Nebraska | Phase 2 |
| Not Yet Recruiting | DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial) NCT07398066 | University of Malaya | N/A |
| Not Yet Recruiting | Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC NCT04298541 | Weill Medical College of Cornell University | Phase 2 |
| Not Yet Recruiting | A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma NCT07533942 | Jazz Pharmaceuticals | Phase 2 |
| Not Yet Recruiting | Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During NCT07493447 | Eben Rosenthal | EARLY_Phase 1 |
| Not Yet Recruiting | A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma NCT07428616 | Exelixis | Phase 2 |
| Not Yet Recruiting | Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With M NCT07418775 | University of California, San Francisco | — |
| Not Yet Recruiting | Measurement of PSMA Expression in Vivo in Recurrent Meningiomas by PET Imaging: a Preliminary Study to a Thera NCT07428213 | Hospices Civils de Lyon | N/A |
| Not Yet Recruiting | Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggress NCT07398170 | University Hospital, Montpellier | N/A |
| Not Yet Recruiting | Pharmacoscopy for Patients With Refractory Primary Brain Tumors NCT06804655 | University of Zurich | Phase 2 |
| Recruiting | Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors NCT07411690 | Medical University of Warsaw | — |
| Not Yet Recruiting | Psychometric Validation of the MQOL-FR and Descriptive Assessment of Quality of Life in Patients With Meningio NCT07376473 | Centre Hospitalier St Anne | — |
| Recruiting | Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Vers NCT07413796 | Medical University of Warsaw | N/A |
| Recruiting | HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer) NCT06930846 | Dartmouth-Hitchcock Medical Center | N/A |
| Recruiting | Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors NCT06831461 | Tata Memorial Centre | N/A |
| Recruiting | Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patient NCT07044076 | Centre Hospitalier St Anne | — |
| Not Yet Recruiting | Proteomic Analysis of Patients Undergoing Bariatric Surgery NCT06787807 | Universidade Federal de Pernambuco | N/A |
| Not Yet Recruiting | DOTATATE PET for Meningioma Radiation Planning NCT06937268 | British Columbia Cancer Agency | N/A |
| Recruiting | Abemaciclib in Newly Diagnosed Meningioma Patients NCT05940493 | Nader Sanai | Phase 2 |
| Recruiting | The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction NCT06874426 | Universitaire Ziekenhuizen KU Leuven | — |
| Recruiting | Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial NCT06132685 | Emory University | Phase 2 |
| Recruiting | Robot-Assisted Neurovascular Intervention NCT06752096 | Navigantis Inc. | N/A |
| Recruiting | Somatostatin Receptor PET Imaging to Guide Radiotherapy Dose Escalation in High Risk Meningiomas. NCT06830356 | Centro di Riferimento Oncologico - Aviano | N/A |
| Recruiting | Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma NCT06557512 | University of California, San Francisco | N/A |
| Recruiting | Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectabl NCT06650163 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Recruiting | Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase NCT06126588 | Central Hospital, Nancy, France | Phase 2 |
| Completed | Semi-automatic Segmentation Method for Determining 177Lu-DOTATATE Tumor Dosimetry NCT06460467 | Central Hospital, Nancy, France | — |
| Completed | Multicenter Evaluation in Patients With MEningiomas of the Response to Treatment With 177LUTEtium-oxodotreotid NCT06255249 | Central Hospital, Nancy, France | — |
| Recruiting | TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas NCT06640582 | Essen Biotech | Phase 1 / Phase 2 |
| Active Not Recruiting | A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent Meningioma NCT06668987 | Heron Neutron Medical Corp. | Phase 1 / Phase 2 |
| Recruiting | Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients - MIND NCT07282470 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | — |
| Recruiting | Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for NCT06607692 | Fundación de investigación HM | Phase 1 / Phase 2 |
| Recruiting | Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE NCT06377371 | Weill Medical College of Cornell University | Phase 4 |
| Completed | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent NCT06322342 | Reveal Pharmaceuticals Inc. | Phase 2 |
| Recruiting | A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors NCT06632860 | Peking Union Medical College Hospital | EARLY_Phase 1 |
| Completed | CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial NCT06439420 | Virginia Commonwealth University | Phase 2 |
| Recruiting | FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery NCT06684795 | Rigshospitalet, Denmark | Phase 2 |
| Recruiting | Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema NCT06710249 | Peter Siesjö | Phase 2 |
| Recruiting | Plasma Extracellular Vesicles in Meningioma Patients NCT06104930 | University Hospital Heidelberg | N/A |
| Enrolling By Invitation | Cryoablation of Brain Neoplasm NCT06753617 | Erasmus Medical Center | N/A |
| Recruiting | Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma: NCT06036706 | Centre Francois Baclesse | N/A |
| Recruiting | Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma NCT06014905 | Javier Villaneuva-Meyer, MD | Phase 1 |
| Unknown | Role of the Tumor Microenvironment in Aggressive Meningiomas NCT05821790 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | Neurocognition After Radiotherapy in CNS- and Skull-base Tumors NCT05727605 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Recruiting | Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors NCT05278208 | Nationwide Children's Hospital | Phase 1 / Phase 2 |
| Recruiting | 3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features NCT06955208 | Shengjing Hospital | N/A |
| Recruiting | Embolization for Meningioma NCT05416567 | St. Olavs Hospital | N/A |
| Not Yet Recruiting | Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas NCT02978677 | Technische Universität Dresden | N/A |
| Recruiting | Evaluation of the CONVIVO System NCT05139277 | Dartmouth-Hitchcock Medical Center | N/A |
| Unknown | Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas Resection NCT05230381 | Beijing Tiantan Hospital | N/A |
| Recruiting | Cabozantinib for Patients With Recurrent or Progressive Meningioma NCT05425004 | Baptist Health South Florida | Phase 2 |
| Completed | Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During Neurosurgery NCT05028400 | Insel Gruppe AG, University Hospital Bern | N/A |
| Unknown | Tranexamic Acid Reduce Blood Loss in Meningioma Resection NCT04386642 | Chiang Mai University | Phase 4 |
| Unknown | Androcur® (Cyproterone Acetate) and Meningioma Development: a Genotype-environment Association Study NCT04372095 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreo NCT04997317 | University Hospital, Basel, Switzerland | Phase 1 / Phase 2 |
| Recruiting | PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI NCT04638478 | Maastricht Radiation Oncology | — |
| Unknown | Use of Non-invasive Optical Analysis in Neurosurgery NCT04712214 | Imperial College London | N/A |
| Recruiting | Predictive Factors for Survival in Aggressive Meningiomas NCT05793034 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Completed | The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection NCT04595786 | Beijing Tiantan Hospital | N/A |
| Completed | Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma NCT04305470 | NX Development Corp | Phase 3 |
| Unknown | Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients. NCT04367779 | Centre Leon Berard | — |
| Active Not Recruiting | Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF NCT04374305 | Scott R. Plotkin, MD, PhD | Phase 2 |
| Terminated | MEningioma Detection Using Non Contrast MRI TecHniquEs NCT04113408 | Fondation Ophtalmologique Adolphe de Rothschild | — |
| Completed | Establishment and Characterization of Meningioma Patient-derived Organoids NCT04478877 | Chinese University of Hong Kong | — |
| Active Not Recruiting | MiDura-Study (Neuro-Patch in Duraplasty) NCT04189172 | Aesculap AG | — |
| Completed | Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadoli NCT04113395 | Fondation Ophtalmologique Adolphe de Rothschild | — |
| Unknown | Cognitive Status After Removal of Skull Base Meningioma NCT04635657 | Ohio State University | — |
| Completed | Closed vs. Open Face Masks for Cranial Radiotherapy NCT04079595 | University of Zurich | N/A |
| Recruiting | Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas NCT03631953 | Assistance Publique Hopitaux De Marseille | Phase 1 |
| Recruiting | 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. NCT04081701 | Weill Medical College of Cornell University | Phase 4 |
| Recruiting | Long-Term Longitudinal QoL in Patients Undergoing EEA NCT04087902 | Ohio State University | — |
| Active Not Recruiting | Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma NCT03971461 | NYU Langone Health | Phase 2 |
| Completed | Meningiomas and Treatment With CYPROTERONE ACETATE or Progestin NCT04109404 | University Hospital, Brest | — |
| Completed | Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas NCT03953131 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Effects of Scalp Nerve Block With Ropivacaine on Postoperative Recovery Quality NCT03648034 | RenJi Hospital | N/A |
| Completed | Magnesium and Intraoperative Blood Loss in Meningioma Surgery NCT03558516 | Mahidol University | Phase 3 |
| Active Not Recruiting | DOTATOC PET/CT for Imaging NET Patients NCT03583528 | British Columbia Cancer Agency | — |
| Completed | Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™ NCT03936426 | Clarity Pharmaceuticals Ltd | Phase 1 / Phase 2 |
| Terminated | Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation NCT03267836 | Washington University School of Medicine | Phase 1 |
| Recruiting | Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology NCT04648462 | Maastricht Radiation Oncology | — |
| Unknown | Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas NCT03071874 | Massachusetts General Hospital | Phase 2 |
| Completed | Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) NCT03273712 | University of Iowa | Phase 2 |
| Recruiting | Liquid Biopsy Evaluation and Repository Development at Princess Margaret NCT03702309 | University Health Network, Toronto | — |
| Terminated | 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors NCT03001349 | M.D. Anderson Cancer Center | EARLY_Phase 1 |
| Terminated | Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors NCT03095248 | Children's Hospital Medical Center, Cincinnati | Phase 2 |
| Withdrawn | Dosimetry Guided PRRT With 90Y-DOTATOC NCT03013387 | Sue O'Dorisio | Phase 2 |
| Active Not Recruiting | Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients NCT02933736 | Nader Sanai | EARLY_Phase 1 |
| Completed | AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas NCT02831257 | Massachusetts General Hospital | Phase 2 |
| Active Not Recruiting | A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas NCT02693990 | Massachusetts General Hospital | N/A |
| Terminated | Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Me NCT02282917 | Massachusetts Eye and Ear Infirmary | EARLY_Phase 1 |
| Recruiting | Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients NCT05576103 | Jona Hattangadi-Gluth | — |
| Completed | Information Presentation Formats NCT02267928 | Carnegie Mellon University | N/A |
| Completed | Molecular-Guided Therapy for Childhood Cancer NCT02162732 | Giselle Sholler | N/A |
| Completed | T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer NCT01967823 | National Cancer Institute (NCI) | Phase 2 |
| Completed | A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery NCT01941602 | St. Olavs Hospital | — |
| Completed | Automated Segmentation and Volumetry for Meningioma Using Deep Learning NCT05093751 | Seoul National University Hospital | — |
| Unknown | Carbon Ion Radiotherapy for Atypical Meningiomas NCT01166321 | University Hospital Heidelberg | N/A |
| Completed | Proton Radiation For Meningiomas and Hemangiopericytomas NCT01117844 | Abramson Cancer Center at Penn Medicine | Phase 1 / Phase 2 |
| Withdrawn | Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients NCT00985036 | Marquette General Health System | — |
| Completed | Monthly SOM230C for Recurrent or Progressive Meningioma NCT00859040 | Patrick Y. Wen, MD | Phase 2 |
| Completed | Stereotactic Body Radiotherapy for Spine Tumors NCT01347307 | Mercy Research | N/A |
| Completed | Evaluation of Brain Functional Changes With 18F-FDG PET and Cognitive Processes After Brain Radiotherapy for C NCT06180226 | IRCCS San Raffaele | — |
| Completed | Combination of Hydroxyurea and Verapamil for Refractory Meningiomas NCT00706810 | University of Utah | Phase 2 |
| Completed | Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma NCT00589784 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Unknown | NF2 Natural History Consortium NCT00004483 | House Ear Institute | — |
| Recruiting | SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON) NCT05254197 | Seoul National University Hospital | — |
| Unknown | Correlation Between Expression of Hormonal Receptors, Clinical Data, and Methylation Profile in Meningiomas (M NCT06278103 | Central Hospital, Nancy, France | — |
| Terminated | Antineoplaston Therapy in Treating Patients With Meningioma NCT00003483 | Burzynski Research Institute | Phase 2 |
| Completed | S9005 Mifepristone in Meningioma NCT03015701 | SWOG Cancer Research Network | Phase 3 |
| Completed | The Etiology and Progression of Brain Tumors NCT01811524 | Tampere University Hospital | — |
| Available | ITM11 Expanded Access Program NCT07497984 | ITM Solucin GmbH | — |